These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16264904)

  • 1. Can molecular markers predict local, regional and distant metastasis in head and neck cancer?
    Haffty BG
    Nat Clin Pract Oncol; 2005 Mar; 2(3):132-3. PubMed ID: 16264904
    [No Abstract]   [Full Text] [Related]  

  • 2. Personalizing cancer care: updates on head and neck cancer.
    de Souza JA; Cohen EE
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1219-22. PubMed ID: 19761425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current role of gene therapy in head and neck cancer.
    Ganly I; Soutar DS; Kaye SB
    Eur J Surg Oncol; 2000 Jun; 26(4):338-43. PubMed ID: 10873352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staging of the neck in patients with head and neck squamous cell cancer: imaging techniques and biomarkers.
    Takes RP
    Oral Oncol; 2004 Aug; 40(7):656-67. PubMed ID: 15172634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiling in head and neck squamous cell carcinoma: Clinical perspectives.
    Lallemant B; Evrard A; Chambon G; Sabra O; Kacha S; Lallemant JG; Lumbroso S; Brouillet JP
    Head Neck; 2010 Dec; 32(12):1712-9. PubMed ID: 20949446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic factors for head and neck cancer].
    Fujieda S
    Gan To Kagaku Ryoho; 2001 Apr; 28(4):440-7. PubMed ID: 11329776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of simultaneous esophageal lesions in head and neck squamous cell carcinoma: a multivariate analysis.
    Chow TL; Lee DT; Choi CY; Chan TT; Lam SH
    Arch Otolaryngol Head Neck Surg; 2009 Sep; 135(9):882-5. PubMed ID: 19770420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should there be more molecular staging of head and neck cancer to improve the choice of treatments and thereby improve survival?
    Almadori G; Bussu F; Paludetti G
    Curr Opin Otolaryngol Head Neck Surg; 2008 Apr; 16(2):117-26. PubMed ID: 18327030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular biomarkers in HNSCC: prognostic and therapeutic implications.
    Hussein MR; Cullen K
    Expert Rev Anticancer Ther; 2001 Jun; 1(1):116-24. PubMed ID: 12113118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in squamous cell carcinomas of the head and neck.
    Liu M; Weynand B; Delos M; Marbaix E
    Acta Otorhinolaryngol Belg; 1999; 53(3):155-60. PubMed ID: 10635383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognosis for the metastasis of squamous cell carcinoma of the head and neck].
    Kakurina GV; Kondakova IV; Choĭnzonov EL
    Vopr Onkol; 2012; 58(1):26-32. PubMed ID: 22629824
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic exploitation of the physiological and molecular genetic alterations in head and neck cancer.
    Le QT; Giaccia AJ
    Clin Cancer Res; 2003 Oct; 9(12):4287-95. PubMed ID: 14555497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of patients with metastatic cancer of unknown primary.
    Ghosh L; Dahut W; Kakar S; Posadas EM; Torres CG; Cancel-Santiago R; Ghosh BC
    Curr Probl Surg; 2005 Jan; 42(1):12-66. PubMed ID: 15711508
    [No Abstract]   [Full Text] [Related]  

  • 14. Metastatic cutaneous squamous cell carcinoma to the parotid and cervical lymph nodes: treatment and outcomes.
    Bumpous J
    Curr Opin Otolaryngol Head Neck Surg; 2009 Apr; 17(2):122-5. PubMed ID: 19346945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic cutaneous squamous cell carcinoma of the head and neck: the Immunosuppression, Treatment, Extranodal spread, and Margin status (ITEM) prognostic score to predict outcome and the need to improve survival.
    Oddone N; Morgan GJ; Palme CE; Perera L; Shannon J; Wong E; Gebski V; Veness MJ
    Cancer; 2009 May; 115(9):1883-91. PubMed ID: 19224549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear localization of Nm23-H1 in head and neck squamous cell carcinoma is associated with radiation resistance.
    Kim SH; Lee SY; Park HR; Sung JM; Park AR; Kang S; Kim BG; Choi YP; Kim YB; Cho NH
    Cancer; 2011 May; 117(9):1864-73. PubMed ID: 21509763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of molecular analysis in detecting cervical lymph node metastasis in head and neck squamous cell carcinoma.
    Elsheikh MN; Rinaldo A; Hamakawa H; Mahfouz ME; Rodrigo JP; Brennan J; Devaney KO; Grandis JR; Ferlito A
    Head Neck; 2006 Sep; 28(9):842-9. PubMed ID: 16691557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of micrometastatic tumor cells in head and neck squamous cell carcinoma. A possible predictor of recurrences?
    Guney K; Yoldas B; Ozbilim G; Derin AT; Sarihan S; Balkan E
    Saudi Med J; 2007 Feb; 28(2):216-20. PubMed ID: 17268699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of molecular markers in the management of head and neck cancers.
    Ferreira MB; De Souza JA; Cohen EE
    Curr Opin Oncol; 2011 May; 23(3):259-64. PubMed ID: 21358329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
    Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
    J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.